Degree and PhD in Medicine at UAB. Postdoctoral stay at the Burnham Institute, California. Since 2000 the group leader CIBBIM Nanomedicine (Hospital Vall d'Hebron), since 2007 he is the coordinator. Since 2011 is scientific deputy director of CIBER BBN and also technology transfer coordinator at CIBER BBN. He has been adviser of biotech companies, is the author of six patents, has been coordinator of over six collaborative projects.

Degree and PhD in Chemistry from the University of Castelló. Postdoctoral stays at the Centre for Polymer Therapeutics (Cardiff, UK) and the Institute Biomar, SA (Madrid). In 2006 he joined the Prince Felipe Research Centre in Valencia, where since 2006 he is group leader in the Polymer Therapeutics Laboratory and screening platform. Participated in collaborative projects, has several patents and is CEO of Polypeptide Therapeutic Solutions S.L

Degree and PhD in Pharmacy from the University of Navarra. Postdoctoral stay at the New York University Medical Center. Since 1998 he he is team leader at theResearch Institute of the Hospital of St. Sant Pau, and Since 2007 also at CIBER BBN in oncology and antitumor drugs. Member of the Executive Committee of the Instituto de Sant Pau. Has participated in collaborative projects and with the industry.

Ph.D. in chemistry from the UB. Several postdoctoral stays in USA and France. He is Professor in the UB and Director of Research in Peptide Milligen / Biosearch (Boston, USA). He Professor of Organic Chemistry at UB and was director of the PCB until 2012. He leads a team at the IRB. He has more than 40 patents and has created several companies biotecnológicas.Es Doctor "Honoris Causa" from the University of Buenos Aires.

Degree and Ph.D. in Biology from the UB. Postdoctoral stay at the ICR in London. In 2003 he joined the R&D center of Almirall taking part in drug discovery projects. In 2009 he joined the CIBER BBN as Project Manager, participating in collaborative projects. Since 2011 he is the CEO of Argon Pharma. He has a master's degree in leadership and management of science at UPF and participated in investment readiness (ESADE) and Growth academy (IESE) pr

Degree and PhD in chemistry from the UB. Specialized in polymer chemistry, drug delivery and medicinal chemistry. He has made a postdoctoral stay at IRB in Barcelona. In 2009 he joined Argon Pharma and is currently the head of R&D and has 3 patents.